Scaling cell and gene therapy programs requires far more than clinical expertise — it demands robust governance, financial modeling and operational infrastructure. This panel dives into the frameworks health systems have built to manage patient identification, insurance authorization, product logistics and outcomes tracking at scale. Leaders share practical guidance for organizations at every stage of cell and gene therapy program development.